Skip to main content
. 2002 Aug;136(8):1117–1126. doi: 10.1038/sj.bjp.0704821

Figure 2.

Figure 2

Development of systolic blood pressure of WKY rats treated with vehicle or rofecoxib at increasing doses (1, 3, 10 and 30 mg kg−1 d−1) for 4 weeks during normal salt intake (0.6%, wt wt−1). Data represent the mean±s.e.mean of n=8 rats. Asterisk indicates significance of control rats to rofecoxib treated rats.